Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
14.60
+0.72 (5.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $211.35 million as of December 20, 2024.
Market Cap
211.35M
Enterprise Value
16.85M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.60
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $211.35M, an increase of 6.61%. That is a compound annual growth rate of 12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 211.35M | 6.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 208.24M |
| SOPHiA GENETICS | 205.96M |
| ADC Therapeutics | 204.98M |
| Inventiva | 202.51M |
| Lexeo Therapeutics | 199.72M |
| Atai Life Sciences | 199.68M |
| MacroGenics | 199.59M |
| Akso Health Group | 198.11M |